C. R. Spresser and A. Fleming, “Central Diabetes Insipidus as a Manifestation of AML Secondary to Temodar Therapy for Pancreatic Neuroendocrine Tumor”, kjm, vol. 4, no. S1, Oct. 2011, doi: 10.17161/kjm.v4i3.11359.